Judy Chang

888 total citations
20 papers, 583 citations indexed

About

Judy Chang is a scholar working on Virology, Epidemiology and Immunology. According to data from OpenAlex, Judy Chang has authored 20 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 10 papers in Epidemiology and 10 papers in Immunology. Recurrent topics in Judy Chang's work include HIV Research and Treatment (13 papers), Immune Cell Function and Interaction (8 papers) and Hepatitis B Virus Studies (6 papers). Judy Chang is often cited by papers focused on HIV Research and Treatment (13 papers), Immune Cell Function and Interaction (8 papers) and Hepatitis B Virus Studies (6 papers). Judy Chang collaborates with scholars based in Australia, United States and Denmark. Judy Chang's co-authors include Sharon R. Lewin, Paul Desmond, Kumar Visvanathan, A. Thompson, Stephen Locarnini, Narelle Skinner, Stephen M. Riordan, Jelica Kurtovic, Paul Cameron and Stephen J. Kent and has published in prestigious journals such as The Journal of Immunology, Hepatology and Journal of Virology.

In The Last Decade

Judy Chang

19 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judy Chang Australia 11 387 299 208 162 145 20 583
Jeffrey Quinn United States 11 273 0.7× 258 0.9× 110 0.5× 107 0.7× 66 0.5× 19 469
Sayuki Iijima Japan 15 445 1.1× 390 1.3× 226 1.1× 137 0.8× 162 1.1× 23 763
Anita Schuch Germany 9 257 0.7× 205 0.7× 269 1.3× 51 0.3× 80 0.6× 10 484
Wang Hj China 7 190 0.5× 61 0.2× 138 0.7× 257 1.6× 157 1.1× 12 484
Anna Antoni Austria 5 411 1.1× 285 1.0× 156 0.8× 24 0.1× 66 0.5× 10 462
Freya Van Houtte Belgium 13 229 0.6× 200 0.7× 130 0.6× 23 0.1× 68 0.5× 21 380
Tayebeh Hashempour Iran 13 116 0.3× 127 0.4× 58 0.3× 123 0.8× 127 0.9× 52 387
Roberto Fernandez-Larsson United States 7 246 0.6× 185 0.6× 69 0.3× 110 0.7× 169 1.2× 9 438
Liangen Chen China 7 162 0.4× 61 0.2× 295 1.4× 123 0.8× 56 0.4× 10 427
MC Jung Germany 3 355 0.9× 548 1.8× 173 0.8× 92 0.6× 32 0.2× 7 602

Countries citing papers authored by Judy Chang

Since Specialization
Citations

This map shows the geographic impact of Judy Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Chang more than expected).

Fields of papers citing papers by Judy Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Chang. The network helps show where Judy Chang may publish in the future.

Co-authorship network of co-authors of Judy Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Judy Chang. A scholar is included among the top collaborators of Judy Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy Chang. Judy Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Youry, Ajantha Rhodes, Carolin Tumpach, et al.. (2025). Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir. Journal of Virology. 99(3). e0167624–e0167624.
2.
Pitman, Matthew C., Niamh Meagher, David J. Price, et al.. (2023). Effect of high dose vitamin D3 on the HIV-1 reservoir: A pilot randomised controlled trial. Journal of Virus Eradication. 9(3). 100345–100345. 2 indexed citations
3.
Chang, Judy, et al.. (2023). GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy. iScience. 26(11). 108165–108165. 3 indexed citations
4.
Gartner, Matthew J., Carolin Tumpach, Ashanti Dantanarayana, et al.. (2022). Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV. AIDS. 37(2). 247–257. 2 indexed citations
5.
Chiu, Chris, Judy Chang, Ashanti Dantanarayana, et al.. (2021). Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy. The Journal of Immunology. 208(1). 54–62. 22 indexed citations
6.
Gartner, Matthew J., Paul R. Gorry, Carolin Tumpach, et al.. (2020). Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection. Retrovirology. 17(1). 24–24. 2 indexed citations
7.
Sluis, Renée M. van der, Jennifer M. Zerbato, Jake W. Rhodes, et al.. (2020). Diverse effects of interferon alpha on the establishment and reversal of HIV latency. PLoS Pathogens. 16(2). e1008151–e1008151. 37 indexed citations
8.
Anderson, Jenny L., Lachlan Gray, Georges Khoury, et al.. (2018). HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro. AIDS. 33(2). 199–209. 7 indexed citations
9.
Lu, Hao, et al.. (2018). The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed. Journal of Virology. 92(13). 26 indexed citations
10.
Rasmussen, Thomas A., James McMahon, Judy Chang, et al.. (2018). The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial. The Lancet HIV. 5(5). e221–e230. 28 indexed citations
11.
McMahon, James, Judy Chang, Surekha Tennakoon, et al.. (2017). Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy. AIDS. 31(9). 1344–1346. 10 indexed citations
12.
Rasmussen, Thomas A., James McMahon, Judy Chang, et al.. (2017). Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome. AIDS. 31(13). 1839–1845. 9 indexed citations
13.
Chang, Judy, Robert Lindsay, Smita Kulkarni, et al.. (2011). Polymorphisms in interferon regulatory factor 7 reduce interferon-α responses of plasmacytoid dendritic cells to HIV-1. AIDS. 25(5). 715–717. 23 indexed citations
14.
Avihingsanon, Anchalee, Sharon R. Lewin, Stephen J. Kerr, et al.. (2010). Efficacy of tenofovir disoproxil fumarate/ emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV–HBV coinfection in Thailand. Antiviral Therapy. 15(6). 917–922. 22 indexed citations
15.
Crane, Megan, Sunee Sirivichayakul, Judy Chang, et al.. (2010). No Increase in Hepatitis B Virus (HBV)-Specific CD8+T Cells in Patients with HIV-1-HBV Coinfections following HBV-Active Highly Active Antiretroviral Therapy. Journal of Virology. 84(6). 2657–2665. 16 indexed citations
16.
Chang, Judy, Sunee Sirivichayakul, Anchalee Avihingsanon, et al.. (2009). Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV Coinfection. Journal of Virology. 83(15). 7649–7658. 35 indexed citations
17.
Meier, Angela, Judy Chang, Hendrik Streeck, et al.. (2008). Rapid loss of dendritic cell and monocyte responses to TLR ligands following venipuncture. Journal of Immunological Methods. 339(2). 132–140. 15 indexed citations
18.
Chang, Judy, Alexander Thompson, Kumar Visvanathan, et al.. (2007). The phenotype of hepatitis B virus–specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology. 46(5). 1332–1340. 41 indexed citations
19.
Visvanathan, Kumar, Narelle Skinner, A. Thompson, et al.. (2006). Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology. 45(1). 102–110. 276 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey Quinn Breakdown of academic impact, for papers by Sayuki Iijima Breakdown of academic impact, for papers by Anita Schuch Breakdown of academic impact, for papers by Wang Hj Breakdown of academic impact, for papers by Anna Antoni Breakdown of academic impact, for papers by Freya Van Houtte Breakdown of academic impact, for papers by Tayebeh Hashempour Breakdown of academic impact, for papers by Roberto Fernandez-Larsson Breakdown of academic impact, for papers by Liangen Chen Breakdown of academic impact, for papers by MC Jung
Rankless by CCL
2026